Jon Husted, in a competitive reelection race, declines to give a position on the mifepristone ban

Jon HustedUnited States Senator for Ohio, responding to questions from Axios; his answer is reported in paraphrase, not quoted directly

Explicitly stayed out

Asked by Axios for his position on Hawley's bill to ban mifepristone, Senator Jon Husted said he had not seen it. Axios reported his answer in paraphrase and did not publish a direct quotation, so no words of Husted's own are on the record; the excerpt held here is the reporter's sentence, quoted verbatim from the source. Husted was facing a competitive reelection race in Ohio at the time.

“Sen. Jon Husted (R-Ohio), who faces a competitive reelection race, told Axios he hasn't seen Hawley's bill when asked for his position on it.”

Reporting

Open source (opens in a new tab)Hawley's abortion pill move puts Republican senators in a bind · AxiosAxios, March 19, 2026. Report on Senate Republican reaction to the Safeguarding Women from Chemical Abortion Act.

Case updates

Tracking Josh Hawley's push to ban the abortion pill

Get an email if the mifepristone bill moves in committee or gains cosponsors, or if candidates sign or reject Hawley's Declaration for Life pledge.

Important updates only. Free. Confirm your email to start. Unsubscribe anytime. How we handle your email.

Conceptual image of generic white tablets in a blister pack beneath a shadow resembling the U.S. Capitol.
Credit: The Dispute Index / AI-generated illustration

Where this statement fits

Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

On March 11, 2026, Senator Josh Hawley introduced the Safeguarding Women from Chemical Abortion Act, which would withdraw the Food and Drug Administration's approval of mifepristone for pregnancy termination, make distributing and labeling the drug for that purpose violations of the Federal Food, Drug and Cosmetic Act, and let women who say chemical abortion harmed them sue its manufacturers. Mifepristone has been approved in the United States since 2000 and is used in a large majority of American abortions. Hawley argues a national ban is the only remedy because the drug can be mailed into states whose own laws restrict abortion. The bill drew seven Republican cosponsors but has not moved out of the Senate Health, Education, Labor and Pensions Committee. On September 16, 2026, Hawley unveiled a four-page "Declaration for Life" and began asking officeholders and candidates to sign it as a commitment to ban the drug. The dispute is over whether Congress should enact that ban.

Read the full case

Source and context

Reporting

Hawley's abortion pill move puts Republican senators in a bind (opens in a new tab) · AxiosAxios, March 19, 2026. Report on Senate Republican reaction to the Safeguarding Women from Chemical Abortion Act.

About this source

The fullest available account of Senate Republican reluctance on the bill, with direct responses from Husted and Tillis, Hawley's reply to Axios, and Marjorie Dannenfelser's criticism of the Trump administration's handling of mifepristone litigation.

Archived copy (opens in a new tab)

Before the quotation

Axios reported that Hawley's push was elevating an issue many Republicans hoped to avoid before the midterms, and that additional abortion restrictions could cost the party support in key races. It asked senators, including Husted and Thom Tillis, for their positions.

After the quotation

Senator Thom Tillis gave Axios the same answer, adding "No" when asked whether Republicans were discussing the issue at all. Senate health committee chairman Bill Cassidy separately told MS NOW he had not seen the legislation.

How this statement is classified

Explicitly stayed out

The label describes this statement's response within the context above.

Why this label?

Husted was asked directly for his position and withheld it, which is a refusal rather than a substantive response. The closest competing label is a finding that this is not a position event at all, since not having read a bill can be a plain statement of fact rather than an evasion. That loses because the question put to him was expressly for his position, and Axios reported the answer alongside Tillis's matching reply. This record carries a lower grade of evidence than the others in the case: the source paraphrases rather than quotes, so the substance is attributable to Husted but the wording is the reporter's.

Recorded on
Published here
People and groups discussed
Josh Hawley

More from this case

Read the full case

Share or embed this statement

Quote card: Jon Husted, Jon Husted, in a competitive reelection race, declines to give a position on the mifepristone banDownload image (PNG)

The embed keeps its attribution link to The Dispute Index. Credit the image to The Dispute Index and link to the statement page.

Cite this record

Publisher
The Dispute Index
Title
Jon Husted, in a competitive reelection race, declines to give a position on the mifepristone ban
First published
Last updated
Permalink
https://disputeindex.com/events/1044-asked-by-axios-for-his-position-on-hawley

Last updated marks the most recent saved version of this published statement.

The Dispute Index. "Jon Husted, in a competitive reelection race, declines to give a position on the mifepristone ban". First published: 2026-09-18. Last updated: 2026-09-26. https://disputeindex.com/events/1044-asked-by-axios-for-his-position-on-hawley